Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Closing Bell 3 October

Grady Wulff
October 3, 2022

Morning Bell 3 October

Grady Wulff
October 3, 2022

Weekly Wrap 30 September

Grady Wulff
September 30, 2022

Morning Bell 30 September

Sophia Mavridis
September 30, 2022

Closing Bell 29 September

Grady Wulff
September 29, 2022

Morning Bell 29 September

Grady Wulff
September 29, 2022

Morning Bell 28 September

Grady Wulff
September 28, 2022

Closing Bell 27 September

Sophia Mavridis
September 27, 2022

Morning Bell 27 September

Sophia Mavridis
September 27, 2022

Closing Bell 26 September

Grady Wulff
September 26, 2022

Morning Bell 26 September

Grady Wulff
September 26, 2022

Morning Bell 23 September

Sophia Mavridis
September 23, 2022